Found: 10
Select item for more details and to access through your institution.
Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 12, p. 2757, doi. 10.1007/s40121-023-00892-0
- By:
- Publication type:
- Article
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.907675
- By:
- Publication type:
- Article
Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.963049
- By:
- Publication type:
- Article
Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.954121
- By:
- Publication type:
- Article
Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing.
- Published in:
- Frontiers in Microbiology, 2023, v. 14, p. 1, doi. 10.3389/fmicb.2023.1112580
- By:
- Publication type:
- Article
Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1239179
- By:
- Publication type:
- Article
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 763, doi. 10.3390/v15030763
- By:
- Publication type:
- Article
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01065-0
- By:
- Publication type:
- Article
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge.
- Published in:
- Nature Communications, 2020, v. 11, p. 1, doi. 10.1038/s41467-020-17972-1
- By:
- Publication type:
- Article